Universal pneumococcal vaccine research reaches key milestone

Researchers report progress toward a universal vaccine against pneumococcal disease, which causes pneumonia, meningitis, and sepsis. The new approach targets a common bacterial component rather than strain-specific capsules, potentially covering all known serotypes. If validated in trials, it could replace current vaccines that require periodic reformulation.

Sources (1)